50 mg/m2 aldoxorubicin

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's SarcomaNCT02029430IBRXPhase 2Completed2016-04-25Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.